1986
DOI: 10.1001/archderm.1986.01660190090023
|View full text |Cite
|
Sign up to set email alerts
|

Aleukemic Leukemia Cutis

Abstract: A 46-year-old man presented with nodular skin lesions, a biopsy specimen of which demonstrated a poorly differentiated malignancy. Touch preparations with histochemical staining and electron microscopy confirmed leukemia cutis. Results from a bone marrow aspirate disclosed focal areas of increased myeloblasts, and cytogenetic analysis revealed an abnormal karyotype as follows 46,XY, t(1;2) (q44p13). Antileukemic therapy resulted in prompt disappearance of the skin nodules, and a return of the patient's bone ma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

1991
1991
2015
2015

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 7 publications
0
8
0
Order By: Relevance
“…65 This aleukaemic leukaemia cutis presentation may spontaneously resolve, although in the majority of cases the patients progress to systemic involvement within the subsequent four months. 4,7,20,57,[66][67][68][69][70][71][72][73][74][75] A 2013 retrospective study of 83 patients aged 2 weeks to 89 years of age with myeloid leukaemia cutis published that 6/34 (18%) patients had aleukaemic leukaemia cutis presentations but that all 34 developed a bone marrow based diagnosis of AML. 6 In addition, 10 of 29 (34%) individuals with charted cytogenetic or molecular genetic results available had an abnormality of the chromosome 11q23 that includes the mixed lineage leukaemia (MLL) locus.…”
Section: Managementmentioning
confidence: 99%
“…65 This aleukaemic leukaemia cutis presentation may spontaneously resolve, although in the majority of cases the patients progress to systemic involvement within the subsequent four months. 4,7,20,57,[66][67][68][69][70][71][72][73][74][75] A 2013 retrospective study of 83 patients aged 2 weeks to 89 years of age with myeloid leukaemia cutis published that 6/34 (18%) patients had aleukaemic leukaemia cutis presentations but that all 34 developed a bone marrow based diagnosis of AML. 6 In addition, 10 of 29 (34%) individuals with charted cytogenetic or molecular genetic results available had an abnormality of the chromosome 11q23 that includes the mixed lineage leukaemia (MLL) locus.…”
Section: Managementmentioning
confidence: 99%
“…Although most extramedullary leukemic infiltration occurs late in the disease, leukemia cutis may be seen in patients with normal or even low white blood cell counts in the peripheral blood. In addition, leukemia cutis may be the first sign of the blastic leukemic transformation of myelodysplastic syndrome (6,8,9). There have been several reported cases of leukemia cutis as the initial manifestation of leukemia relapse or as a precursor ofleukemia cell appearance in the peripheral blood (6,8,10).…”
Section: Commentsmentioning
confidence: 99%
“…In addition, leukemia cutis may be the first sign of the blastic leukemic transformation of myelodysplastic syndrome (6,8,9). There have been several reported cases of leukemia cutis as the initial manifestation of leukemia relapse or as a precursor ofleukemia cell appearance in the peripheral blood (6,8,10). Cutaneous infiltration by leukemic cells is regarded as one sign of a poor prognosis (2).…”
Section: Commentsmentioning
confidence: 99%
“…Non-specific lesions are found in up to 30% of leukaemia patients (1), but leukaemia cutis is much less common. Skin involvement is usually a late occurrence, and leukaemia cutis preceding marrow or peripheral blood abnormality is extremely rare (2). The clinical manifestations of leukaemia cutis are variable, including macules, nodules, purpura, and erythroderma, and the condition often resembles cutaneous lymphoma.…”
Section: Discussionmentioning
confidence: 99%